Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Grand View Research | PRODUCT CODE: 1529636

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1529636

Network Point-of-Care Glucose Testing Market Size, Share & Trends Analysis Report By Product (i-STAT, Accu-Chek Inform II, StatStrip, HemoCue, CareSens Expert Plus), By Region, And Segment Forecasts, 2024 - 2030

PUBLISHED:
PAGES: 90 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 5950
Printable PDF (5-User License)
USD 6950
Printable PDF (Enterprise License)
USD 8950

Add to Cart

Network Point-of-Care Glucose Testing Market Growth & Trends:

The global network point-of-care glucose testing market size is expected to reach USD 1.79 billion by 2030, registering a CAGR of 4.4% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing demand for safe and accurate remote patient monitoring options and the need for data-based treatment regimens are major factors driving the market. The integration of advanced technologies including Bluetooth Low Energy (BLE) and Infrared is expected to fuel the market growth in the upcoming years.

Expanding patient base in Asia Pacific and the Middle East and the high demand for advanced diabetes management systems are creating significant growth opportunities in these regions. These regions also include some of the highly preferred destinations for medical tourism. Increasing demand for world-class healthcare services and rising adoption of advanced technology are some of the factors boosting the market growth in these regions.

Network point-of-care glucose meters were extensively used in COVID-19 care. This enabled doctors to remotely observe glucose levels with minimal risk of infection. In addition, a large amount of data is still being used to customize treatment plans for diabetic COVID-19 patients. Preference for telemedicine and trends of home healthcare settings for chronic patients are some of the factors expected to expand the applications of network-based point-of-care devices.

Network Point-of-Care Glucose Testing Market Report Highlights:

  • Network point-of-care devices were in high demand during the first and second wave of COVID-19 owing to their advantage of remote patient monitoring
  • Based on product, the Accu-Chek Inform II segment dominated the market and accounted for a revenue share of 48.4% in 2023 and is expected to expand at a lucrative growth rate during the forecast period
  • North America dominated the market with a revenue share of 40.7% in 2023 and is predicted to maintain its lead over the forecast period owing to the factors such as the presence of major players and high adoption rate
Product Code: GVR-4-68039-609-7

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Network Point-of-Care Glucose Testing Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Network Point-of-Care Glucose Testing Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Network Point-of-Care Glucose Testing Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Network Point-of-Care Glucose Testing Market: Product Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. i-STAT
    • 4.3.1. i-STAT Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Accu-Chek Inform II
    • 4.4.1. Accu-Chek Inform II Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. StatStrip
    • 4.5.1. StatStrip Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. HemoCue
    • 4.6.1. HemoCue Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. CareSens Expert Plus
    • 4.7.1. CareSens Expert Plus Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.8. BAROzen H Expert Plus
    • 4.8.1. BAROzen H Expert Plus Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Network Point-of-Care Glucose Testing Market: Regional Estimates & Trend Analysis

  • 5.1. Network Point-of-Care Glucose Testing Market Share, By Region, 2023 & 2030 (USD Million)
  • 5.2. North America
    • 5.2.1. North America Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.2.2. U.S.
      • 5.2.2.1. U.S. Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.2.3. Canada
      • 5.2.3.1. Canada Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.2.4. Mexico
      • 5.2.4.1. Mexico Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.3. Europe
    • 5.3.1. Europe Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.2. UK
      • 5.3.2.1. UK Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.3. Germany
      • 5.3.3.1. Germany Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.4. France
      • 5.3.4.1. France Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.5. Italy
      • 5.3.5.1. Italy Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.6. Spain
      • 5.3.6.1. Spain Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.7. Denmark
      • 5.3.7.1. Denmark Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.8. Sweden
      • 5.3.8.1. Sweden Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.9. Norway
      • 5.3.9.1. Norway Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Asia Pacific
    • 5.4.1. Asia Pacific Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.2. Japan
      • 5.4.2.1. Japan Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.3. China
      • 5.4.3.1. China Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.4. India
      • 5.4.4.1. India Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.5. Australia
      • 5.4.5.1. Australia Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.6. South Korea
      • 5.4.6.1. South Korea Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.7. Thailand
      • 5.4.7.1. Thailand Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Latin America
    • 5.5.1. Latin America Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.2. Brazil
      • 5.5.2.1. Brazil Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.3. Argentina
      • 5.5.3.1. Argentina Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Middle East and Africa
    • 5.6.1. Middle East and Africa Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.2. South Africa
      • 5.6.2.1. South Africa Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.3. Saudi Arabia
      • 5.6.3.1. Saudi Arabia Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.4. UAE
      • 5.6.4.1. UAE Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.5. Kuwait
      • 5.6.5.1. Kuwait Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis by Key Market Participants
  • 6.2. Company Categorization
  • 6.3. Company Heat Map Analysis
  • 6.4. Company Profiles
    • 6.4.1. Abbott, LLC
      • 6.4.1.1. Participant's Overview
      • 6.4.1.2. Financial Performance
      • 6.4.1.3. Product Benchmarking
      • 6.4.1.4. Recent Developments/Strategic Initiatives
    • 6.4.2. Nova Biomedical
      • 6.4.2.1. Participant's Overview
      • 6.4.2.2. Financial Performance
      • 6.4.2.3. Product Benchmarking
      • 6.4.2.4. Recent Developments/Strategic Initiatives
    • 6.4.3. Danaher
      • 6.4.3.1. Participant's Overview
      • 6.4.3.2. Financial Performance
      • 6.4.3.3. Product Benchmarking
      • 6.4.3.4. Recent Developments/Strategic Initiatives
    • 6.4.4. F. Hoffmann-La Roche Ltd.
      • 6.4.4.1. Participant's Overview
      • 6.4.4.2. Financial Performance
      • 6.4.4.3. Product Benchmarking
      • 6.4.4.4. Recent Developments/Strategic Initiatives
    • 6.4.5. Ascensia Diabetes Care Holdings AG.
      • 6.4.5.1. Participant's Overview
      • 6.4.5.2. Financial Performance
      • 6.4.5.3. Product Benchmarking
      • 6.4.5.4. Recent Developments/Strategic Initiatives
    • 6.4.6. Prodigy Diabetes Care, LLC
      • 6.4.6.1. Participant's Overview
      • 6.4.6.2. Financial Performance
      • 6.4.6.3. Product Benchmarking
      • 6.4.6.4. Recent Developments/Strategic Initiatives
    • 6.4.7. Nipro Corporation Japan
      • 6.4.7.1. Participant's Overview
      • 6.4.7.2. Financial Performance
      • 6.4.7.3. Product Benchmarking
      • 6.4.7.4. Recent Developments/Strategic Initiatives
    • 6.4.8. ACON Laboratories, Inc.
      • 6.4.8.1. Participant's Overview
      • 6.4.8.2. Financial Performance
      • 6.4.8.3. Product Benchmarking
      • 6.4.8.4. Recent Developments/Strategic Initiatives
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!